(3R)-1-[(4-thiophen-2-ylphenyl)methyl]-3-[[3-(trifluoromethoxy)phenyl]sulfonylmethyl]pyrrolidine
C23H22F3NO3S2 — CID 153219831
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3R)-1-[(4-thiophen-2-ylphenyl)methyl]-3-[[3-(trifluoromethoxy)phenyl]sulfonylmethyl]pyrrolidine
(3R)-1-[(4-thiophen-2-ylphenyl)methyl]-3-[[3-(trifluoromethoxy)phenyl]sulfonylmethyl]pyrrolidine (PubChem CID 153219831) has the molecular formula C23H22F3NO3S2 and a molecular weight of 481.56 g/mol. Its IUPAC name is (3R)-1-[(4-thiophen-2-ylphenyl)methyl]-3-[[3-(trifluoromethoxy)phenyl]sulfonylmethyl]pyrrolidine.
Molecular Properties
| Compound Name | (3R)-1-[(4-thiophen-2-ylphenyl)methyl]-3-[[3-(trifluoromethoxy)phenyl]sulfonylmethyl]pyrrolidine |
|---|---|
| PubChem CID | 153219831 |
| Molecular Formula | C23H22F3NO3S2 |
| Molecular Weight | 481.56 g/mol |
| Exact Mass | 481.10 |
| IUPAC Name | (3R)-1-[(4-thiophen-2-ylphenyl)methyl]-3-[[3-(trifluoromethoxy)phenyl]sulfonylmethyl]pyrrolidine |
| SMILES | O=S(=O)(C[C@@H]1CCN(Cc2ccc(-c3cccs3)cc2)C1)c1cccc(OC(F)(F)F)c1 |
| InChI | InChI=1S/C23H22F3NO3S2/c24-23(25,26)30-20-3-1-4-21(13-20)32(28,29)16-18-10-11-27(15-18)14-17-6-8-19(9-7-17)22-5-2-12-31-22/h1-9,12-13,18H,10-11,14-16H2/t18-/m1/s1 |
| InChIKey | WNKUPIFVBILLHQ-GOSISDBHSA-N |
| XLogP | 5.61 |
| TPSA | 46.61 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 481.56 |
| LogP ≤ 5 | 5.61 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153219831 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.